US Physical Therapy (USPH) Gets a Buy Rating from Barrington

By Carrie Williams

In a report released today, Michael Petusky from Barrington maintained a Buy rating on US Physical Therapy (USPHResearch Report), with a price target of $130.00. The company’s shares closed last Monday at $119.18.

According to, Petusky is a 3-star analyst with an average return of 2.8% and a 49.4% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Varian Medical Systems, Merit Medical Systems, and Anika Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for US Physical Therapy with a $130.00 average price target.

See today’s analyst top recommended stocks >>

Based on US Physical Therapy’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $10.81 million. In comparison, last year the company had a net profit of $1.7 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The company was founded in 1990 and is headquartered in Houston, TX.